Vasodilator therapy in patients with aortic insufficiency: A systematic review

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 454-461

  Mahajerin, Ali ^a   Gurm, Hitinder S ^a   Tsai, Thomas T ^a   Chan, Paul S ^a   Nallamothu, Brahmajee K ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; HYDRALAZINE; NIFEDIPINE; PLACEBO; VASODILATOR AGENT;

AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; DEMOGRAPHY; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFECT; HEART HEMODYNAMICS; HUMAN; LONG TERM CARE; MEDLINE; OUTCOME ASSESSMENT; PATIENT INFORMATION; PRIORITY JOURNAL; REVIEW; SCISEARCH; SYSTEMATIC REVIEW; TREATMENT DURATION; VASODILATATION;

AORTIC VALVE INSUFFICIENCY; HUMANS; VASODILATOR AGENTS;

EID: 33947379702     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.006     Document Type: Review

References (50)

1. Bonow R.O., Rosing D.R., McIntosh C.L., et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation 68 (1983) 509-517
2. Goldschlager N., Pfeifer J., Cohn K., et al. The natural history of aortic regurgitation. A clinical and hemodynamic study. Am J Med 54 (1973) 577-588
3. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48 (2006) e1-e148
4. Bashore T.M. Afterload reduction in chronic aortic regurgitation: it sure seems like a good idea. J Am Coll Cardiol 45 (2005) 1031-1033
5. Bonow R.O. Management of chronic aortic regurgitation. N Engl J Med 331 (1994) 736-737
6. Carabello B.A. Vasodilators in aortic regurgitation-where is the evidence of their effectiveness?. N Engl J Med 353 (2005) 1400-1402
7. Levine H.J., and Gaasch W.H. Ratio of regurgitant volume to end-diastolic volume: a major determinant of ventricular response to surgical correction of chronic volume overload. Am J Cardiol 52 (1983) 406-410
8. Greenberg B.H., DeMots H., Murphy E., et al. Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency. Circulation 63 (1981) 263-268
9. Fioretti P., Benussi B., Scardi S., et al. Afterload reduction with nifedipine in aortic insufficiency. Am J Cardiol 49 (1982) 1728-1732
10. Shen W.F., Roubin G.S., Hirasawa K., et al. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. J Am Coll Cardiol 4 (1984) 902-907
11. Scognamiglio R., Rahimtoola S.H., Fasoli G., et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 331 (1994) 689-694
12. Evangelista A., Tornos P., Sambola A., et al. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 353 (2005) 1342-1349
13. Greenberg B., Massie B., Bristow J.D., et al. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation 78 (1988) 92-103
14. Juni P., Witschi A., Bloch R., et al. The hazards of scoring the quality of clinical trials for meta-analysis. Jama 282 (1999) 1054-1060
15. Sondergaard L., Aldershvile J., Hildebrandt P., et al. Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation. Am Heart J 139 (2000) 667-674
16. Banaszewski M., Rydlewska-Sadowska W., and Rubkiewicz S. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation. J Heart Valve Dis 7 (1998) 488-499
17. Lin M., Chiang H.T., Lin S.L., et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 24 (1994) 1046-1053
18. Wilson R., Perlmutter N., Jacobson N., et al. Effects of long-term vasodilator therapy on electrocardiographic abnormalities in chronic aortic regurgitation. Am J Cardiol 68 (1991) 935-939
19. Scognamiglio R., Fasoli G., Ponchia A., et al. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 16 (1990) 424-429
20. Kleaveland J.P., Reichek N., McCarthy D.M., et al. Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation. Am J Cardiol 57 (1986) 1109-1116
21. Wisenbaugh T., Sinovich V., Dullabh A., et al. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 3 (1994) 197-204
22. Rothlisberger C., Sareli P., and Wisenbaugh T. Comparison of single dose nifedipine and captopril for chronic severe mitral regurgitation. Am J Cardiol 73 (1994) 978-981
23. Hoffmann U., Frank H., Stefenelli T., et al. Afterload reduction in severe aortic regurgitation. J Magn Reson Imaging 14 (2001) 693-697
24. Gentile F., Ornaghi M., Esposti D., et al. Hemodynamic effects of nifedipine in patients with asymptomatic aortic regurgitation: evaluation by Doppler echocardiography. Acta Cardiol 48 (1993) 495-506
25. Scognamiglio R., Fasoli G., Visintin L., et al. Effects of unloading and positive inotropic interventions on left ventricular function in asymptomatic patients with chronic severe aortic insufficiency. Clin Cardiol 10 (1987) 804-810
26. Butman S.M., Eagan J., and Olson H.G. Hemodynamic effects of verapamil in left ventricular valvular volume overload. Am Heart J 110 (1985) 416-426
27. Shen W.F., Roubin G.S., Hirasawa K., et al. Abnormal left ventricular response to isometric exercise in pure, isolated aortic regurgitation: beneficial effects of nifedipine. Am J Cardiol 54 (1984) 605-609
28. Elkayam U., McKay C.R., Weber L., et al. Favorable effects of hydralazine on the hemodynamic response to isometric exercise in chronic severe aortic regurgitation. Am J Cardiol 53 (1984) 1603-1607
29. Fioretti P., Benussi B., Klugmann S., et al. Acute hemodynamic effects of nifedipine at rest and during stress in severe aortic incompetence. Eur Heart J 4 (1983) 110-116
30. Sasayama S., Ohyagi A., Lee J.D., et al. Effect of the vasodilator therapy in regurgitant valvular disease. Jpn Circ J 46 (1982) 433-441
31. Slosky D.A., Hindman M.C., Peter R.H., et al. Effects of oral hydralazine on rest and exercise hemodynamics in patients with aortic or mitral regurgitation and left ventricular dysfunction. Clin Cardiol 4 (1981) 162-167
32. Durairaj M., Handekar S.N., Kher H.L., et al. After load reduction therapy with nitroprusside in chronic severe aortic regurgitation. A non invasive assessment. Indian Heart J 32 (1980) 373-377
33. Greenberg B.H., DeMots H., Murphy E., et al. Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency. Circulation 62 (1980) 49-55
34. Hockings B.E., Cope G.D., Clarke G.M., et al. Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation. Br Heart J 43 (1980) 550-555
35. Wilson J.R., Reichek N., and Hirshfeld J. Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation. Am J Med 68 (1980) 664-674
36. Miller R.R., Vismara L.A., DeMaria A.N., et al. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume. Am J Cardiol 38 (1976) 564-567
37. Bolen J.L., and Alderman E.L. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 53 (1976) 879-883
38. Warner R.A., Bowser M., Zuehlke S., et al. Treatment of acute aortic insufficiency with sodium nitroferricyanide. Documentation of beneficial effect by noninvasive means. Chest 72 (1977) 375-379
39. Scognamiglio R., Fasoli G., Visintin L., et al. Variability of positive inotropic response to acute amrinone administration in chronic cardiac failure. Eur Heart J 7 (1986) 621-627
40. Reske S.N., Heck I., Kropp J., et al. Captopril mediated decrease of aortic regurgitation. Br Heart J 54 (1985) 415-419
41. Scognamiglio R., Negut C., Palisi M., et al. Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. J Am Coll Cardiol 45 (2005) 1025-1030
42. Nauman D., Greenberg B., Massie B., et al. Effects of stopping long-term vasodilator therapy in patients with chronic aortic insufficiency. Chest 102 (1992) 720-724
43. Acar J., Michel P.L., Luxereau P., et al. How to manage patients with severe left ventricular dysfunction and valvular regurgitation. J Heart Valve Dis 5 (1996) 421-429
44. Jensen T., Kornerup H.J., Lederballe O., et al. Treatment with hydralazine in mild to moderate mitral or aortic incompetence. Eur Heart J 4 (1983) 306-312
45. Crawford M.H., Wilson R.S., O'Rourke R.A., et al. Effect of digoxin and vasodilators on left ventricular function in aortic regurgitation. Int J Cardiol 23 (1989) 385-393
46. Schon H.R., Dorn R., Barthel P., et al. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 3 (1994) 500-509
47. Globits S., Blake L., Bourne M., et al. Assessment of hemodynamic effects of angiotensin-converting enzyme inhibitor therapy in chronic aortic regurgitation by using velocity-encoded cine magnetic resonance imaging. Am Heart J 131 (1996) 289-293
48. Dumesnil J.G., Tran K., and Dagenais G.R. Beneficial long-term effects of hydralazine in aortic regurgitation. Arch Intern Med 150 (1990) 757-760
49. Greenberg B.H., and Rahimtoola S.H. Long-term vasodilator therapy in aortic insufficiency. Evidence for regression of left ventricular dilatation and hypertrophy and improvement in systolic pump function. Ann Intern Med 93 (1980) 440-442
50. Bonow R.O., Carabello B., deLeon A.C., et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 7 (1998) 672-707